Assessing cellular energy dysfunction in CFS/ME using a commercially available laboratory test
Cara Tomas, Tiffany A Lodge, Michelle Potter, Joanna L Elson, Julia L Newton, Karl J Morten, Cara Tomas, Tiffany A Lodge, Michelle Potter, Joanna L Elson, Julia L Newton, Karl J Morten
Abstract
The mitochondrial energy score (MES) protocol, developed by the Myhill group, is marketed as a diagnostic test for chronic fatigue syndrome/Myalgic Encephalomyelitis (CFS/ME). This study assessed the reliability and reproducibility of the test, currently provided by private clinics, to assess its potential to be developed as an NHS accredited laboratory test. We replicated the MES protocol using neutrophils and peripheral blood mononuclear cells (PBMCs) from CFS/ME patients (10) and healthy controls (13). The protocol was then repeated in PBMCs and neutrophils from healthy controls to investigate the effect of delayed sample processing time used by the Myhill group. Experiments using the established protocol showed no differences between CFS/ME patients and healthy controls in any of the components of the MES (p ≥ 0.059). Delaying blood sample processing by 24 hours (well within the 72 hour time frame quoted by the Myhill group) significantly altered many of the parameters used to calculate the MES in both neutrophils and PBMCs. The MES test does not have the reliability and reproducibility required of a diagnostic test and therefore should not currently be offered as a diagnostic test for CFS/ME. The differences observed by the Myhill group may be down to differences in sample processing time between cohorts.
Conflict of interest statement
The authors declare no competing interests.
Figures
References
- NICE. Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy) - Diagnosis and management of CFS/ME in adults and children (2007).
- Marks DF. Special issue on the PACE Trial. Journal of Health and Psychology. 2017;22:1103–1105. doi: 10.1177/1359105317722370.
- Tomas C, et al. Cellular bioenergetics is impaired in patients with chronic fatigue syndrome. PLOS ONE. 2017;12:e0186802. doi: 10.1371/journal.pone.0186802.
- Filler K, et al. Association of mitochondrial dysfunction and fatigue: A review of the literature. BBA Clinical. 2014;1:12–23. doi: 10.1016/j.bbacli.2014.04.001.
- Fluge, O. et al. Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome. JCI Insight1 (2016).
- Lawson, N., Hsieh, C. H., March, D. & Wang, X. Elevated Energy Production in Chronic Fatigue Syndrome Patients. Journal of Nature and Science2 (2016).
- Myhill S, Booth NE, McLaren-Howard J. Chronic fatigue syndrome and mitochondrial dysfunction. International Journal of Clinical and Experimental Medicine. 2009;2:1–16.
- Booth NE, Myhill S, McLaren-Howard J. Mitochondrial dysfunction and the pathophysiology of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) International Journal of Clinical and Experimental Medicine. 2012;5:208–220.
- Myhill S, Booth NE, McLaren-Howard J. Targeting mitochondrial dysfunction in the treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) - A clinical audit. International Journal of Clinical and Experimental Medicine. 2013;6:1–15.
- Cox IM, Campbell MJ, Dowson D. Red blood cell magnesium and chronic fatigue syndrome. The Lancet. 1991;337:757–760. doi: 10.1016/0140-6736(91)91371-Z.
- Manuel YKB, et al. Magnesium status and parameters of the oxidant-antioxidant balance in patients with chronic fatigue: Effects of supplementation with magnesium. Journal of the American College of Nutrition. 2000;19:374–382. doi: 10.1080/07315724.2000.10718934.
- Deulofeu R, Gascon J, Giménez N, Corachan M. Magnesium and chronic fatigue syndrome. The Lancet. 1991;338:641. doi: 10.1016/0140-6736(91)90655-9.
- Ko YH, Hong S, Pedersen PL. Chemical mechanism of ATP synthase. Magnesium plays a pivotal role in formation of the transition state where ATP is synthesized from ADP and inorganic phosphate. Journal of Biological Chemistry. 1999;274:28853–28856. doi: 10.1074/jbc.274.41.28853.
- Chacko BK, et al. Methods for defining distinct bioenergetic profiles in platelets, lymphocytes, monocytes, and neutrophils, and the oxidative burst from human blood. Laboratory Investigation. 2013;93:690–700. doi: 10.1038/labinvest.2013.53.
- Borregaard NH. T. Energy Metabolism of Human Neutrophils during Phagocytosis. Journal of Clinical Investigation. 1982;70:550–557. doi: 10.1172/JCI110647.
- Maianski NA, et al. Functional characterization of mitochondria in neutrophils: a role restricted to apoptosis. Cell death and differentiation. 2004;11:143–153. doi: 10.1038/sj.cdd.4401320.
- Maianski NA, Maianski AN, Kuijpers TW, Roos D. Apoptosis of neutrophils. Acta Haemotologica. 2004;111:56–66. doi: 10.1159/000074486.
- Karnovsky ML. The metabolism of leukocytes. Seminars in Haemotology. 1968;5:156–165.
- Dagur PK, McCoy JP., Jr. Collection, Storage, and Preparation of Human Blood Cells. Current Protocols in Cytometry. 2016;73:5.1.1–5.1.16.
- Buescher ES, Gallin JI. Effects of storage and radiation on human neutrophil function in vitro. Inflammation. 1987;11:401–416. doi: 10.1007/BF00915984.
- Potter M, Newport E, Morten KJ. The Warburg effect: 80 years on. Biochemical Society Transactions. 2016;44:1499–1505. doi: 10.1042/BST20160094.
- Tak T, Tesselaar K, Pillay J, Borghans JA, Koenderman L. What’s your age again? Determination of human neutrophil half-lives revisited. Journal of Leukocyte Biology. 2013;94:595–601. doi: 10.1189/jlb.1112571.
- Lood C, et al. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nature Medicine. 2016;22:146–153. doi: 10.1038/nm.4027.
- Carruthers BM, et al. Myalgic encephalomyelitis/chronic fatigue syndrome: Clinical working case definition, diagnostic and treatment protocols. Journal of Chronic Fatigue Syndrome. 2003;11:7–115. doi: 10.1300/J092v11n01_02.
Source: PubMed